Attention and working memory abilities in children treated for acute lymphoblastic leukemia
- PMID: 20572038
- PMCID: PMC2946517
- DOI: 10.1002/cncr.25343
Attention and working memory abilities in children treated for acute lymphoblastic leukemia
Abstract
Background: To extend investigation beyond global cognitive measures prevalent in the literature, this study examined attention and working memory (WM) abilities of survivors of childhood acute lymphoblastic leukemia (ALL), the separate contributions of attention and WM to intelligence quotient (IQ), and their association with neuroimaging changes.
Methods: Ninety-seven children with ALL received risk-directed therapy based on presenting clinical and biological factors. During consolidation therapy, low-risk patients received half the dose of intravenous methotrexate that standard-risk/high-risk patients received, and fewer doses of triple intrathecal therapy. Patients were classified according to end of consolidation magnetic resonance imaging scans (normal or leukoencephalopathy), and continuous measures of white matter structure were computed. As part of the protocol study, children completed cognitive assessment 2 years later (completion of therapy), using Digit Span Forward (DSF) for attention and Digit Span Backward (DSB) for WM.
Results: For the total sample and the standard-/high-risk group, Total Digit Span (TDS), DSF, and DSB were impaired relative to norms (P<.05). In the low-risk group, only DSB was impaired (P<.0001). Across groups, a higher percentage of patients performed below the average range (scale score<7) on DSB (66%) compared with the DSF (14%) or TDS (18%). Regression analysis indicated that DSB predicted estimated IQ (P<.05), after accounting for DSF. Leukoencephalopathy was predictive of lower TDS (P<.05).
Conclusions: WM appears to be especially sensitive to treatment-related changes in ALL survivors, detecting difficulties potentially missed by global intelligence measures. These findings may facilitate the identification of vulnerable neural pathways and the development of targeted cognitive interventions.
Copyright © 2010 American Cancer Society.
Figures


Similar articles
-
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.Lancet Haematol. 2016 Oct;3(10):e456-e466. doi: 10.1016/S2352-3026(16)30110-7. Epub 2016 Sep 14. Lancet Haematol. 2016. PMID: 27658980 Free PMC article.
-
Developmental trajectories of forward and backward digit spans in deaf children with cochlear implants.Cochlear Implants Int. 2011 May;12 Suppl 1(Suppl 1):S84-8. doi: 10.1179/146701011X13001035752534. Cochlear Implants Int. 2011. PMID: 21756483 Free PMC article.
-
Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.J Clin Oncol. 2016 Apr 10;34(11):1239-47. doi: 10.1200/JCO.2015.64.3205. Epub 2016 Feb 8. J Clin Oncol. 2016. PMID: 26858334 Free PMC article.
-
Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.Cancer. 2002 Dec 15;95(12):2562-70. doi: 10.1002/cncr.10999. Cancer. 2002. PMID: 12467071
-
[Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].Med Wieku Rozwoj. 2012 Apr-Jun;16(2):128-37. Med Wieku Rozwoj. 2012. PMID: 22971657 Review. Polish.
Cited by
-
Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort.Pediatr Blood Cancer. 2013 Nov;60(11):1778-84. doi: 10.1002/pbc.24644. Epub 2013 Jun 18. Pediatr Blood Cancer. 2013. PMID: 23775832 Free PMC article.
-
Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.J Clin Oncol. 2013 Dec 10;31(35):4407-15. doi: 10.1200/JCO.2012.48.2315. Epub 2013 Nov 4. J Clin Oncol. 2013. PMID: 24190124 Free PMC article.
-
Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.J Clin Exp Neuropsychol. 2014;36(8):818-30. doi: 10.1080/13803395.2014.943695. Epub 2014 Aug 15. J Clin Exp Neuropsychol. 2014. PMID: 25126830 Free PMC article.
-
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.Support Care Cancer. 2017 Feb;25(2):449-457. doi: 10.1007/s00520-016-3422-9. Epub 2016 Oct 10. Support Care Cancer. 2017. PMID: 27726029 Free PMC article. Clinical Trial.
-
Chemotherapy and the pediatric brain.Mol Cell Pediatr. 2018 Nov 6;5(1):8. doi: 10.1186/s40348-018-0087-0. Mol Cell Pediatr. 2018. PMID: 30402806 Free PMC article. Review.
References
-
- Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch of Clin Neuropsychol. 2000;15(7):603–30. - PubMed
-
- Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil. 2004;7(1):1–14. discussion 15–6. - PubMed
-
- Brown RW, Madan-Swain A, Pais R, et al. Cognitive status of children treated with central nervous system prophylactic chemotherapy for acute lymphocytic leukemia. Arch of Clin Neuropsychol. 1992;7:481–97. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials